Latest Leverage News

BCAL Diagnostics has launched its Avantect blood tests for pancreatic and ovarian cancer with encouraging early uptake and is advancing its BREASTESTplus breast cancer test towards broader clinical use.

Prairie Lithium has retracted its previous production target citing compliance issues, while announcing a binding offtake agreement with South Korea’s Hydro Lithium for its Phase 1 lithium output. This move signals a strategic shift towards selling intermediate lithium products to reduce costs and accelerate market entry.

Elevate Uranium has announced a significant upgrade to its Marenica Uranium Project in Namibia, doubling the resource grade and increasing contained uranium. This milestone enhances the project's development prospects and underpins the company's growth strategy.

Klevo Rewards Limited’s subsidiary Fly Wallet has secured key Mastercard compliance and earned over AUD 550,000 in incentives, marking a significant step in its payments platform evolution.

Jcurve Solutions has reported a robust first half of FY26, posting a 32% increase in revenue and a remarkable 478% jump in EBITDA, while upgrading its full-year revenue guidance amid ongoing customer churn challenges.

Tungsten Mining NL has launched a Project Economic Evaluation to explore accelerated development of its Watershed Project, leveraging existing approvals to potentially fast-track production in a tightening tungsten market.

RPMGlobal Holdings Limited shares will be suspended from the ASX following Federal Court approval of its acquisition by a Caterpillar subsidiary, marking a significant ownership change.

Codeifai Limited has raised $1.1 million through a share placement that coincided with a sharp increase in its share price, confirming full compliance with ASX disclosure rules following a detailed inquiry.

Garda Property Group has upgraded its FY26 earnings guidance by 10%, reduced gearing to 20.8%, and outlined ambitious plans to expand its Brisbane industrial portfolio and lending operations.

Cauldron Energy’s latest groundwater analysis at the Yanrey Uranium Project reveals low chloride and sulphate levels, affirming the site’s suitability for environmentally friendly in situ recovery uranium mining. This milestone supports the company’s plans to expand resources and advance towards production.

Cyclopharm Limited is accelerating its US market push for Technegas with a A$16 million capital raise following a record 2025 sales performance. The company aims to expand its US installations and advance new clinical applications beyond pulmonary embolism.

PYC Therapeutics has successfully closed a $537 million institutional placement and entitlement offer, positioning the company to raise at least $600 million to advance its RNA-based therapies targeting genetic diseases.